MAGNI, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 7.945
EU - Europa 5.428
AS - Asia 4.554
SA - Sud America 1.273
AF - Africa 251
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 3
Totale 19.470
Nazione #
US - Stati Uniti d'America 7.797
SG - Singapore 1.435
VN - Vietnam 1.068
UA - Ucraina 1.053
BR - Brasile 990
RU - Federazione Russa 964
SE - Svezia 698
CN - Cina 644
DE - Germania 560
IE - Irlanda 485
TR - Turchia 434
DK - Danimarca 393
FR - Francia 383
IT - Italia 323
FI - Finlandia 282
HK - Hong Kong 269
KR - Corea 218
GB - Regno Unito 148
CI - Costa d'Avorio 101
AR - Argentina 93
IN - India 89
BD - Bangladesh 82
CA - Canada 61
IQ - Iraq 57
MX - Messico 57
ZA - Sudafrica 53
ID - Indonesia 51
EC - Ecuador 50
CO - Colombia 43
MA - Marocco 33
PK - Pakistan 32
VE - Venezuela 31
PL - Polonia 28
UZ - Uzbekistan 26
PY - Paraguay 24
JP - Giappone 23
BE - Belgio 22
NL - Olanda 19
MY - Malesia 16
CL - Cile 15
PH - Filippine 15
EU - Europa 14
TN - Tunisia 13
ES - Italia 12
KE - Kenya 12
EG - Egitto 11
DZ - Algeria 10
JO - Giordania 9
PE - Perù 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
BO - Bolivia 8
LT - Lituania 7
TH - Thailandia 7
UY - Uruguay 7
BY - Bielorussia 6
GT - Guatemala 6
HU - Ungheria 6
OM - Oman 6
TW - Taiwan 6
AL - Albania 5
DO - Repubblica Dominicana 5
IL - Israele 5
KZ - Kazakistan 5
AT - Austria 4
CH - Svizzera 4
GE - Georgia 4
KG - Kirghizistan 4
MD - Moldavia 4
NP - Nepal 4
SN - Senegal 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
LV - Lettonia 3
PS - Palestinian Territory 3
RO - Romania 3
ZW - Zimbabwe 3
AM - Armenia 2
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
HR - Croazia 2
JM - Giamaica 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
Totale 19.452
Città #
Jacksonville 1.043
Ashburn 829
Singapore 814
Chandler 532
Boardman 490
Dublin 484
New York 413
Fairfield 403
Dallas 389
Wilmington 346
Ho Chi Minh City 332
San Jose 303
Hong Kong 252
Hanoi 242
Lawrence 208
Princeton 208
San Mateo 208
Lauterbourg 182
Seattle 181
Houston 177
Woodbridge 173
The Dalles 171
Ann Arbor 161
Beijing 154
Des Moines 141
Moscow 123
Cambridge 114
Hefei 110
Abidjan 101
São Paulo 86
Los Angeles 78
Helsinki 72
San Diego 62
Munich 56
Da Nang 50
Haiphong 46
Marche 43
Buffalo 38
Chennai 31
Rio de Janeiro 31
Orem 28
Shanghai 26
Baghdad 24
Chicago 24
Johannesburg 24
Tashkent 24
Warsaw 24
Belo Horizonte 23
Centro 23
Ottawa 23
Guangzhou 22
Hải Dương 22
Brussels 21
London 20
Norwalk 19
Brasília 18
Santa Clara 18
Tokyo 18
Brooklyn 17
Campinas 17
Guayaquil 17
Izmir 16
Thái Nguyên 16
Ogden 15
Salvador 15
Thái Bình 15
Curitiba 14
Dhaka 14
Manchester 14
Porto Alegre 14
Can Tho 13
Denver 13
Milan 13
Montreal 13
Ninh Bình 13
Quito 13
Wuhan 13
Asunción 12
Biên Hòa 12
Bogotá 12
Cape Town 12
Nairobi 12
San Francisco 12
Atlanta 11
Frankfurt am Main 11
Poplar 11
Amsterdam 10
Joinville 10
Manaus 10
Venice 10
Guarulhos 9
Ha Long 9
Jiaxing 9
Phoenix 9
Boston 8
Goiânia 8
Kuala Lumpur 8
Nonantola 8
Quận Ba 8
Rome 8
Totale 10.782
Nome #
Baker's yeast UMP:pyrophosphate phosphoribosyltransferase. Purification, enzymatic and kinetic properties. 359
Assay methods for nicotinamide mononucleotide adenylyltransferase of wide applicability 187
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration 184
A spectrophotometric method for the assay of pyrimidine 5'-nucleotidase in human erythrocytes. 179
Characterization of human nicotinate phosphoribosyltransferase: kinetic studies, structure prediction and functional analysis by site-directed mutagenesis 170
Inactivation of uridine nucleosidase in yeast. Purification and properties of an inactivating protein. 167
A comparative study of some properties of cytidine deaminase from Escherichia coli and chicken liver 162
Purification of human cytidine deaminase. Molecular and enzymatic characterization and inhibition by synthetic pyrimidine analogs 158
The genetic basis of hemolytic anemia caused by pyrimidine 5' nucleotidase deficiency. 157
Bifunctional NMN adenylyltransferase/ADP-ribose pyrophosphatase: structure and function in bacterial NAD metabolism. 156
Carattirizzazione di una preparazione omogenea di NMN adenililtrasferasi da placenta umana. Procedura di purificazione, analisi cinetica e proprietà molecolari. 152
Enzymology of NAD+ homeostasis in man 152
Identification of a novel human nicotinamide mononucleotide adenylyltransferase 149
Characterization of Mycobacterium tuberculosis NAD kinase: functional analysis of the full-length enzyme by site-directed mutagenesis. 143
Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: New insights on structure and function relationship. 142
Further properties of cytidine deaminase and uridine phosphorylase from E.coli B. 141
A novel fold revealed by Mycobacterium tuberculosis NAD kinase, a key allosteric enzyme in NADP biosynthesis 139
Biosintesi del NAD in Mycobacterium tubercolosis: clonaggio ed espressione dei geni nadD e nadR. 139
Synthesis and biological evaluation of NAD analogs as human pyridine nucleotide adenylyltransferase inhibitors. 139
Nicotinamide mononucleotide synthetase is the key enzyme for an alternative route of NAD biosynthesis in Francisella tularensis. 138
Crystal structure of human nicotinic acid phosphoribosyltransferase 135
Cytidine deaminase from Escherichia coli B. Enzymatic and molecular properties. 134
Activation of succinate dehydrogenase by succinate 133
Baker's yeast cytidine deaminase: Substrate and inhibitor specificity, and a hypothesis on metabolic and regulatory significance 130
Enzymology of mammalian NAD metabolism in health and disease. 129
Purificazione, microsequenziamento, clonaggio ed espressione della pirimidina 5’-nucleotidasi (PN-I) da eritrocita umano e sua identificazione come p36, una proteina indotta dall’interferone. 128
Approccio allo studio della sequenza della NMN adenililtrasferasi da testicolo bovino. 127
Biosintesi del NAD: studi preliminari sull'NMN adenililtrasferasi da Sulfolobus solfataricus. 126
Purification of cytidine deaminase from chicken liver. 126
Clonaggio ed espressione di geni da Mycobacterium tuberculosis coinvolti nella sintesi del NAD. 125
Biosintesi del NAD in microorganismi termofili. NMN adenililtrasferasi da Sulfolobus solfataricus. 125
Simultaneous quantification of nicotinamide mononucleotide and related pyridine compounds in mouse tissues by UHPLC–MS/MS 125
ATP:NMN adenylyltransferase: its relationship to poly ADP-ribosylation 122
Characterization of nicotinamide mononucleotide adenylyltransferase from thermophilic archaea 121
Baker's yeast cytosine deaminase. Some enzymic properties and allosteric inhibition by nucleosides and nucleotides 121
Caratterizzazione strutturale e funzionale dell’NMN adeniltrasferasi umana ricombinante. 120
Bakers' yeast uridine nucleosidase is a regulatory copper containing protein. 119
Azione di diversi effettori sul comportamento cinetico dell'NMN adenililtrasferasi da placenta umana. 119
Uridine phosphorylase from Escherichia coli B. Enzymatic and molecular properties. 118
Induction of pyrimidine nucleosides metabolizing enzymes in E.coli B 116
Pyridine nucleotide metabolism: Purification and properties of NMN adenylyltransferase from human placenta 116
NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration. 115
Attività fosfotrasferasica di nucleotidasi pirimidiniche nel globulo rosso umano. 115
ATP:NMN adenylyltransferase from baker's yeast: further properties 114
The Enzymology of Cytosolic Pyrimidine 5'-Nucleotidases: Functional Analysis and Physiopathological Implications. 114
Baker's yeast nmn adenylyltransferase 113
Initial-rate kinetics of human NMN-adenylyltransferases: substrate and metal ion specificity, inhibition by products and multisubstrate analogues, and isozyme contributions to NAD+ biosynthesis. 113
Baker's yeast uridine nucleosidase. II. Enzymatic and kinetic properties 112
Caratterizzazione di una preparazione omogenea di NMN adenililtrasferasi da placenta umana. Procedura di purificazione, analisi cinetica e proprietà molecolari. 112
NMN adenylyltransferase from bull testis: purification and properties 110
A one-step procedure for the purification of uridine phosphorylase from Escherichia coli 110
Baker's yeast UMP:pyrophosphate phosphoribosyltransferase. Purification, enzymatic and molecular properties. 110
Biosintesi del NAD: studi sulle proprietà strutturali e funzionali dell'NMN adenililtrasferasi da placenta umana. 110
Simultaneous single-sample determination of NMNAT isozyme activities in mouse tissues 110
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. 110
Kinetic evidence for covalent phosphoryl-enzyme intermediate in phosphotransferase activity of human red cell pyrimidine nucleotidases 110
Baker's yeast uridine nucleosidase. I. Purification to homogeneity 109
Three-minute high-performance liquid chromatographic assay for NMN adenylyltransferase using a 20-mm-long reversed-phase column 108
Structural and functional properties of NAD kinase, a key enzyme in NADP biosynthesis. 107
Unique expression pattern of human nicotinamide mononucleotide adenylyltransferase isozymes in red blood cells 106
Structure of nicotinamide mononucleotide adenylyltransferase: a key enzyme in NAD biosynthesis 105
Cloning and characterization of a new human NMN adenylyltransferase. 105
WldS protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice 104
Pyrimidine nucleoside catabolizing enzymes in Escherichia coli B. 104
Nicotinamide mononucleotide adenylyltransferase from Sulfolobus solfataricus 102
Cytidine deaminase from human spleen. 102
Una nuova NMN adeniltrasferasi umana: clonaggio, espressione eterologa e caratterizzazione della proteina KIAA0479. 101
Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration. 101
Metabolismo del NAD+ in placenta umana: NMN adenililtrasferasi. 101
WLDS CAN DELAY WALLERIAN DEGENERATION IN MICE WHEN INTERACTION WITH VALOSIN-CONTAINING PROTEIN IS WEAKENED. 100
The antitumor drug 1,3-bis-(2-chloroethyl)-1-nitrosourea inactivates human NMN adenylyltransferase 100
5' Nucleotidase: some properties of guinea pig skeletal muscle and bovine milk serum enzyme 100
Nicotinamide-mononucleotide adenylyltransferase from Methanococcus jannaschii 100
Induction studies on enzymes involved in the metabolism of pyrimidine nucleosides in E.coli B. 99
Expression studies of NMN adenylyltransferase in human cultured cell lines. 99
NAD(P) biosynthesis enzymes as potential targets for selective drug design. 99
Cloning and expression of archaeal NMN adenylyltransferase gene. 99
Homogeneous pyrimidine nucleotidase from human erythrocyte. Enzymatic and molecular properties 98
Presence of a specific uridine 5'-monophosphate pyrophosphorylase in baker's yeast. 97
NAD homeostasis regulation: a novel cyanobacterial bifunctional enzyme possessing NMN adenylyltransferase and ADP-ribose pyrophosphatase activities. 97
Synechocystis sp. slr0787 protein is a novel bifunctional enzyme endowed with both nicotinamide mononucleotide adenylyltransferase and "Nudix" hydrolase activities. 95
Metabolism of NAD+ in the nuclei of human placenta 95
Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase 94
Uridine nucleosidase from yeast 94
NAD biosynthesis in human placenta: characterization of homogeneous NMN adenylyltransferase. 94
Mycobacterium tuberculosis NAD (P) BIOSYNTHETIC ENZYMES AS NOVEL ANTIMICROBIAL DRUG TARGETS 93
Nuclear matrix associated NMN adenylyltransferase activity in human placenta 92
Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues 91
Evidence for an inhibitory effect exerted by Yeast NMN Adenylyltransferase on Poly(ADP-ribose)-Polymerase activity. 91
Uridine phosphorylase from Escherichia coli B.: Kinetic studies on the mechanism of catalysis 91
Yeast NMN adenylyltransferase: novel approach to rapid purification 91
Pyrimidine nucleotidases/phosphotransferases from human erythrocyte. 91
Pyrimidine nucleotidases/phosphotransferases from human erythrocyte 91
Identification of a novel enzyme possessing both NMN adenylyltransferase and «nudix» hydrolase activity. Preliminary characterization of the recombinant protein. 90
Regolazione dell'attività della poli( ADP-riboso ) polimerasi da parte di NMN adenililtrasferasi. 90
Purification of human nicotinamide mononucleotide adenylyltransferase 90
Studi sulla struttura primaria dell’enzima NMN adeniltrasferasi. 89
Spectrophotometric assays for 5'-nucleotidase, using IMP, GMP and CMP as substrates 88
Ruolo dell'enzima NMN adenililtrasferasi nella risposta cellulare allo stress termico. 88
NMN adenililtrasferasi e poli(ADP-riboso)polimerasi: correlazione funzionale in un sistema omologo ricostituito. 88
Totale 11.875
Categoria #
all - tutte 90.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021361 0 0 0 0 0 0 0 0 0 0 265 96
2021/20221.248 44 396 5 74 5 55 45 91 121 83 54 275
2022/20232.183 229 248 222 129 147 270 6 133 668 12 68 51
2023/20241.429 252 37 75 240 242 369 17 24 1 11 7 154
2024/20252.572 315 244 174 57 83 61 224 62 719 147 187 299
2025/20266.661 405 541 484 977 615 422 1.282 743 529 580 83 0
Totale 19.668